N-Benzyl-imidazoles as selective inhibitors of the thromboxane
申请人:Pfizer Inc.
公开号:US04448781A1
公开(公告)日:1984-05-15
The N-(substituted benzyl) imidazoles are selective enzyme inhibitors and thus are useful in the treatment of heart disease, circulatory and vascular problems.